Suchergebnisse - "Huang, Xin"

PubPharm (6.662)

21

AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells

enthalten in: ResearchSquare.com | 2024

von Costa-Verdera, H. | Meneghini, V. | Fitzpatrick, Z. | +18

22

Arthroscopic and open approaches for autologous matrix-induced chondrogenesis repair of the knee have similar results : a meta-analysis

enthalten in: Journal of ISAKOS : joint disorders & orthopaedic sports medicine | 2024

von Tan, C. | Huang, X. | Tay, Z. | +1

23

Flexible sensors with zero Poisson's ratio

enthalten in: National science review | 2024

von Huang, X. | Bu, T. | Zheng, Q. | +7

24

Genome-wide identification and characterization of the sweet orange (Citrus sinensis) basic helix-loop-helix (bHLH) family reveals a role for CsbHLH085 as a regulator of citrus bacterial canker resistance

enthalten in: International journal of biological macromolecules | 2024

von Huang, X. | Su, L. | Xian, B. | +11

25

Multiple-polarization-sensitive photodetector Based on a plasmonic metasurface

enthalten in: Nanoscale | 2024

von Bai, Q. | Huang, X. | Du, S. | +5

26

Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude

enthalten in: Pharmaceutical development and technology | 2024

von Wang, C. | Huang, X. | Tang, Z. | +9

27

A spatiotemporal atlas of mouse liver homeostasis and regeneration

enthalten in: Nature genetics | 2024

von Xu, J. | Guo, P. | Hao, S. | +55

28

Suitability of inorganic coagulants for algae-laden water treatment : Trade-off between algae removal and cell viability, aggregate properties and coagulant residue

enthalten in: Journal of hazardous materials | 2024

von Wang, L. | Al-Dhabi, N. | Huang, X. | +4

29

Efficacy and safety of combined microneedling therapy for androgenic alopecia : A systematic review and meta-analysis of randomized clinical trials

enthalten in: Journal of cosmetic dermatology | 2024

von Pei, D. | Zeng, L. | Huang, X. | +3

30

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13) : A Phase 2 Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Lou, H. | Cai, H. | Huang, X. | +10